Ekopath Metropolis Lab Services Private Limited, a active private limited company, was established on 14 February 2013 in Mumbai, Maharashtra, India. Engaging in diagnostic centers & pathology labs within the hospital and medical care sector, it holds CIN: U93000MH2013PTC240481. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.10 M and a paid-up capital of ₹5.10 M.
It upholds a compliant status. Employing 33 professional, Its leadership includes Ronica Baruah (Director), Nilesh Jadavji Shah (Director), Aditya Vijay Shinde (Additional Director). Past directors included Mangesh Hanmant Kulkarni, Tushar Manohar Karnik, Rakesh Kumar Agarwal. Its latest AGM occurred on 16 September 2025, with the balance sheet filed on 31 March 2025. It is based at 4Th Floor Office(Entire Floor) Block 4.2 Kohinoor City, Kirol Road Kurla(West) Of, F Lbs Marg, Mumbai, Maharashtra, 400070.
U93000MH2013PTC240481
240481
14 February 2013
₹5.10 M
₹5.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Ekopath Metropolis Lab Services Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ronica Baruah | Director | 14 Feb 2013 | Current |
| Nilesh Jadavji Shah | Director | 14 Feb 2013 | Current |
| Aditya Vijay Shinde | Additional Director | 15 Nov 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 Mar 2016 | Past |
| Pramod Abcsdd | Director | 11 Nov 2019 | Past |
| Pramod Abcsdd | Additional Director | 15 Sep 2020 | Past |
| Pramod Abcsdd | Director | 30 Mar 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ekopath Metropolis Lab Services Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.67% increase. The company also saw a slight improvement in profitability, with a 1.18% increase in profit. The company's net worth Soared by an impressive increase of 27.29%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Ekopath Metropolis Lab Services had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Ekopath Metropolis Lab Services has a workforce of 33 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Ekopath Metropolis Lab Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ekopath Metropolis Lab Services's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Ekopath Metropolis Lab Services Private Limited last Annual general meeting of members was held on 16 Sep 2025 as per latest MCA records. was documented.
Ekopath Metropolis Lab Services Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
Aditya Vijay Shinde was appointed as a Additional Director was appointed as a Additional Director on 15 Nov 2024 & has been associated with this company since 1 year 1 month . was recorded as a recent event.
Progress on Ronica Baruah was appointed as a Director was appointed as a Director on 14 Feb 2013 & has been associated with this company since 12 years 10 months . was documented.
The activity Nilesh Jadavji Shah was appointed as a Director was appointed as a Director on 14 Feb 2013 & has been associated with this company since 12 years 10 months . was completed.
The activity Ekopath Metropolis Lab Services Private Limited was registered on 14 Feb 2013 with Roc Mumbai & aged 12 years 10 months as per MCA records. was completed.
Metropolis Healthcare Ltd on Monday said it has received a Rs 24.46 crore income tax demand from the income tax authority.An income tax demand of Rs 24.46 cror....
Metropolis Healthcare bought 4 labs in Surat for 18 crore rupees to expand their subsidiary. The company's MD said consolidation is good for the diagnostic industry. Metropolis has 13 labs and 300 service centers in Gujarat. The 4 labs made 7.4 crore rupees in 2017-18. Metropolis made 760 crore rupees in 2018-19. The diagnostic industry is unorganized and fragmented, so bigger companies are buying smaller labs. A report says the market will grow by 27.5% in 5 years. Metropolis' stock closed 1.8% lower at 1,250 rupees..
Mumbai : Metropolis Healthcare, a leading diagnostic service provider with a pan India presence, has launched Hypersensitivity Pneumonitis (HP) Profile, a new series of test for timely diagnosis of Hy.
The ₹1,204-crore Metropolis Healthcare IPO, with a price band of ₹877-880, was subscribed 5.84 times.It was an offer for sale and the company will not receive any funds raised from the issue.
The CIN of Ekopath Metropolis Lab Services Private Limited is U93000MH2013PTC240481.
Ekopath Metropolis Lab Services Private Limited is headquartered at 4Th Floor Office(Entire Floor) Block 4.2 Kohinoor City, Kirol Road Kurla(West) Of, F Lbs Marg, Mumbai, Maharashtra, 400070.
Ekopath Metropolis Lab Services Private Limited was incorporated on 14 February 2013.
The current directors of Ekopath Metropolis Lab Services Private Limited are
The primary industry of Ekopath Metropolis Lab Services Private Limited is Hospital And Medical Care.
Ekopath Metropolis Lab Services Private Limited is unlisted.
The authorized capital of Ekopath Metropolis Lab Services Private Limited is ₹5.10 M, and the paid-up capital is ₹5.10 M.
The compliance status of Ekopath Metropolis Lab Services Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX